Risk of valuation differences and valuation losses due to share price declines
First written in FY2016. 15 of 30 entries say "Materialised", first in FY2017-Q2. Latest entry: FY2026.
Nippon Felt moved to the "Worse" side of this theme in 2018, 1 year before the typical company in this theme (2019).
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
28 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The Group holds listed shares, and a substantial decline in share prices could affect the Group’s performance and financial position through a decrease in valuation differences on other securities and the recognition of impairment losses, among other factors.」
The company continues to disclose the risk of declining share prices and decreases in valuation differences associated with holding marketable shares. During the fiscal year, the valuation difference on other securities increased by ¥1,965 million, and no impairment loss was recorded. - FY2025RestatedAnnual report
「The Group holds listed shares, and a substantial decline in share prices could affect the Group’s performance and financial position through a decrease in valuation differences on other securities and the recognition of impairment losses, among other factors.」
The company continues to disclose the risk of declining share prices and decreases in valuation differences associated with holding marketable shares. - FY2025-H1MaterialisedAnnual report
「Net assets decreased by ¥182 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥353 million decrease in the valuation difference on other securities, partly offset by increases of ¥91 million in retained earnings and ¥77 million in the foreign currency translation adjustment.」
The valuation difference on other securities decreased by ¥353 million, and the decrease in the valuation difference on marketable securities is reflected in net assets as an actual result. A decline in share prices is not specifically identified as the cause. - FY2023RestatedAnnual report
「The Group holds listed shares, and a substantial decline in share prices could affect the Group’s performance and financial position through a decrease in valuation differences on other securities and the recognition of impairment losses, among other factors.」
The company continues to disclose the risk of declining share prices and decreases in valuation differences associated with holding marketable shares. No impairment loss on securities was recorded for the fiscal year. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company states that there have been no material changes in its existing business and other risks, including the risk of valuation differences and valuation losses resulting from declining share prices. - FY2023-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company states that there have been no material changes in its existing business and other risks, including the risk of valuation differences and valuation losses resulting from declining share prices. - FY2022MaterialisedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥134.053 million on securities, all of which related to shares classified as other securities.」
The company actually recorded an impairment loss on investment securities and impairment charges of ¥134.053 million related to declines in the prices of marketable shares and other factors. - FY2022-Q3MaterialisedAnnual report
「Impairment loss on investment securities 121,294 129,681」
The company recorded an impairment loss on investment securities of ¥129.681 million during the nine-month period of the fiscal year, indicating that valuation losses on marketable securities continued to occur in practice. - FY2022-Q2MaterialisedAnnual report
「The company also recorded a ¥106 million impairment loss on investment securities as an extraordinary loss」
The company recorded a ¥106 million impairment loss on investment securities as an extraordinary loss, indicating that valuation losses resulting from fluctuations in market prices, including share prices, actually occurred. - FY2022-Q1MaterialisedAnnual report
「Quarterly net income attributable to owners of the parent was ¥77 million, mainly due to the recording of a ¥101 million impairment loss on investment securities as an extraordinary loss.」
The company recorded a ¥101 million impairment loss on investment securities as an extraordinary loss, and the risk of valuation losses on marketable securities has materialized as an actual loss. - FY2021-Q3MaterialisedAnnual report
「Impairment loss on investment securities — 121,294」
The company recorded an impairment loss on investment securities of ¥121.294 million as an extraordinary loss during the nine-month period of the fiscal year, indicating that valuation losses resulting from fluctuations in market prices, including share prices, actually occurred. - FY2021-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company states that there have been no material changes in its existing business and other risks, including the risk of valuation differences and valuation losses resulting from declining share prices. - FY2021-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It states that no new business or other risks have arisen and that there have been no material changes. - FY2020MaterialisedAnnual report
「Net assets decreased by ¥654 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥669 million decrease in the valuation difference on other securities, partly offset by a ¥166 million increase in retained earnings.」
The valuation difference on other securities decreased by ¥669 million, and the decrease in valuation differences resulting from fluctuations in market prices, including share prices, is significantly reflected in net assets. - FY2020-Q3MaterialisedAnnual report
「This was mainly due to decreases of ¥65 million in the valuation difference on other securities and ¥27 million in the foreign currency translation adjustment, partly offset by a ¥107 million increase in retained earnings.」
The valuation difference on other securities decreased by ¥65 million, and the decrease in the valuation difference on marketable securities is reflected in net assets. - FY2020-Q2MaterialisedAnnual report
「Net assets decreased by ¥294 million from the end of the previous consolidated fiscal year. This was mainly due to decreases of ¥307 million in the valuation difference on other securities and ¥25 million in the foreign currency translation adjustment, partly offset by an ¥83 million increase in retained earnings.」
The valuation difference on other securities decreased by ¥307 million, and the decrease in the valuation difference on marketable securities is reflected in net assets. - FY2020-Q1MaterialisedAnnual report
「Net assets decreased by ¥281 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥247 million decrease in the valuation difference on other securities.」
The valuation difference on other securities decreased by ¥247 million, and the decrease in the valuation difference on marketable securities is reflected in net assets. - FY2019MaterialisedAnnual report
「Net assets decreased by ¥294 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥456 million decrease in the valuation difference on other securities, partly offset by a ¥253 million increase in retained earnings.」
The valuation difference on other securities decreased by ¥456 million. Although no impairment loss on investment securities was recorded for the fiscal year, the decrease in the valuation difference on marketable securities is reflected in the financial position. - FY2019-Q3MaterialisedAnnual report
「Net assets decreased by ¥478 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥696 million decrease in the valuation difference on other securities, partly offset by a ¥217 million increase in retained earnings.」
The valuation difference on other securities actually decreased by ¥696 million. Although a decline in share prices is not specifically identified as the cause, fluctuations in the value of marketable securities are reflected as a decrease in valuation differences. - FY2019-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It explicitly states that there have been no material changes in existing business and other risks. - FY2019-Q1MaterialisedAnnual report
「This was mainly due to decreases of ¥279 million in cash and deposits, ¥259 million in notes and accounts receivable, and ¥122 million in investment securities, while merchandise and finished goods increased by ¥111 million, work in process by ¥51 million, and property, plant and equipment by ¥120 million.」
Investment securities decreased by ¥122 million in the first quarter. Although a decline in share prices is not specifically identified as the cause, fluctuations in the value of marketable securities are reflected in the financial position, together with the decrease in valuation differences. - FY2018MaterialisedAnnual report
「During the current consolidated fiscal year, the Group recorded an impairment loss of ¥34 million on investment securities.」
In connection with the risk of impairment losses on investment securities resulting from falling share prices and other factors, an actual impairment loss of ¥34 million was recognized. - FY2018-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It explicitly states that there have been no material changes in existing business and other risks. - FY2018-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It explicitly states that there have been no material changes in existing business and other risks. - FY2018-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It explicitly states that there have been no material changes in existing business and other risks. - FY2017RestatedAnnual report
「The Group holds listed shares, and a substantial decline in share prices could affect the Group’s performance and financial position through a decrease in valuation differences on other securities and the recognition of impairment losses, among other factors.」
Again describes the risk of falling share prices associated with holding listed shares. - FY2017-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
Explicitly states that there have been no material changes in existing business and other risks, with no new impairment losses reported. - FY2017-Q2MaterialisedAnnual report
「Impairment loss on investment securities － 32,750」
In connection with the risk of impairment losses resulting from falling share prices and other factors, the Group recognized an impairment loss on investment securities of ¥32.75 million as an extraordinary loss in the cumulative second quarter of the current consolidated fiscal year. - FY2017-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It explicitly states that there have been no material changes in existing business and other risks. - FY2016First statedAnnual report
「A substantial decline in share prices could affect the Group’s performance and financial position through a decrease in valuation differences on other securities and the recognition of impairment losses, among other factors.」
Describes the risk of market price fluctuations associated with holding listed shares.